The table contains 11 products whose active ingredient are classified under the same pharmacologic class Complement Inhibitors [MoA].
|
NDC |
Proprietary Name |
Non-Proprietary Name |
Dosage Form |
Route Name |
Company Name |
Status |
| 25682-001 | Soliris | Non-Proprietary Name: Eculizumab | Injection, Solution, Concentrate | Intravenous | Alexion Pharmaceuticals Inc. | ACTIVE |
| 25682-022 | Ultomiris | Non-Proprietary Name: Ravulizumab | Solution, Concentrate | Intravenous | Alexion Pharmaceuticals Inc. | ACTIVE |
| 25682-025 | Ultomiris | Non-Proprietary Name: Ravulizumab | Solution, Concentrate | Intravenous | Alexion Pharmaceuticals Inc. | ACTIVE |
| 25682-028 | Ultomiris | Non-Proprietary Name: Ravulizumab | Solution, Concentrate | Intravenous | Alexion Pharmaceuticals Inc. | ACTIVE |
| 50474-990 | Zilbrysq | Non-Proprietary Name: Zilucoplan | Injection, Solution | Subcutaneous | Ucb, Inc. | ACTIVE |
| 50474-991 | Zilbrysq | Non-Proprietary Name: Zilucoplan | Injection, Solution | Subcutaneous | Ucb, Inc. | ACTIVE |
| 50474-992 | Zilbrysq | Non-Proprietary Name: Zilucoplan | Injection, Solution | Subcutaneous | Ucb, Inc. | ACTIVE |
| 61755-014 | Veopoz | Non-Proprietary Name: Pozelimab | Injection, Solution | Intravenous; Subcutaneous | Regeneron Pharmaceuticals, Inc. | ACTIVE |
| 73606-010 | Empaveli | Non-Proprietary Name: Pegcetacoplan | Injection, Solution | Subcutaneous | Apellis Pharmaceuticals, Inc. | ACTIVE |
| 73606-020 | Syfovre | Non-Proprietary Name: Pegcetacoplan | Injection, Solution | Intravitreal | Apellis Pharmaceuticals, Inc. | ACTIVE |
| 82829-002 | Izervay | Non-Proprietary Name: Avacincaptad Pegol | Injection | Intravitreal | Astellas Pharma Us, Inc. | ACTIVE |